Pharma white papers on contemporary issues, technologies, research, etc. are presented in this section to enable the readers with rich information and knowledge. This section provides white papers related to all the spheres of the pharma industry.
Summary The target market for conducting global clinical trials has changed significantly moving beyond pharmaceutical early adopters to the mainstream marketplace This shift has placed a heightened focus on the language challenges and complexity of running a global clinical trial More and more co..
Summary Validation of Pure Steam and the verification of the final aqueous rinse in a CIP process are defined by regulatory standards which change periodically and challenge system designers and owners to know the latest requirements This white paper contains an overview of current pharmacopeia req..
Summary Randomized doubleblind clinical trials are the gold standard for adequate and wellcontrolled studies in modern times However prior to the late 1940s randomization and blinding were not used in medicine and as result bias was common For example treatment bias was often observed as physicians..
Summary This white paper will explore current trends related to procurement and sourcing is evolving role in the supplier discovery process and current practices for accessing supplier information It will explore the ability of new technology to enable procurement and sourcing professionals to reduc..
Summary Serialisation has emerged as a complex challenge for the pharmaceuticals sector which is facing a multiplicity of differing regulations that vary from one country to another Several countries including China South Korea Turkey Argentina and Brazil already have regulations in place that must..
Summary Every business faces risk Broadly speaking the primary categories of business risk are Market Financial Execution and Regulatory Successful companies have developed a core competency in managing for these risks turning risk management into a sustainable competitive advantage For drug manufa..
Summary The Institute for Clinical and Economic Review ICER held a Policy Summit on December 9 11 2015 with 44 health care leaders from the 22 payer and life sciences organizations that comprise the ICER membership group The purpose of the meeting was to explore the potential value of indicationsp..
Summary Contract manufacturing can enhance the drug development process by creating effective processes increasing manufacturing efficiencies and reducing overhead costs Selecting a CMO with two essential characteristics capability and partnershipchemistry is often difficult and challenging This wh..
Summary The World Health Organization WHO defines a counterfeit medication as a medication that is deliberately and fraudulently mislabelled with respect to identity andor source According to WHO counterfeiting can apply to both branded and generic products and can include products with the correct..
Summary The Indian pharmaceutical industry is today the fourth largest globally in volume terms and 13th largest in value terms and continues to grow annually at 14 The industry is making significant IT investments to support this growth This paper surveys the IT usage in the Pharma industry It de..